Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-24 @ 4:37 PM
NCT ID:
NCT03173066
Eligibility Criteria:
Inclusion Criteria:
* Patients with a clinical suspicion for pulmonary embolus
* estimated glomerular filtration rate (eGFR) \<30mL/min/1.73m2
* have been clinically disqualified from the use of iodine-based contrast studies, gadolinium-based contrast studies or nuclear-based detection studies
Exclusion Criteria:
* received ferumoxytol in the previous six months
* anaphylactic reaction to other intravenous iron formulations
* calculated estimated glomerular filtration rate is \>50mL/min/1.78m2
* patients on dialysis with no residual renal function
* pregnant women and nursing mothers. Standard screening will be used by
* patients \>65 years of age with BMI \>45, and/or liver disease (Child-Pugh class C)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT03173066
Study Brief:
Protocol Section:
NCT03173066